Friday, May 27, 2016 - Saturday, May 27, 2017 12:00 AM
At the conclusion of this activity, participants should be able to:
- Identify the premyeloma conditions;
- Identify factors that can influence the outcome of patients with multiple myeloma;
- Identify current treatment options for symptomatic patients; and
- Recognize the limitation of newly approved drugs in managing multiple myeloma.
Indiana University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Indiana University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.